Get the Stockscreener App
44.67
0.79%
0.35
After Hours:
44.67
Qiagen Nv stock is traded at $44.67, with a volume of 1.32M.
It is up +0.79% in the last 24 hours and up +6.13% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
See More
Previous Close:
$44.32
Open:
$43.84
24h Volume:
1.32M
Relative Volume:
1.43
Market Cap:
$9.93B
Revenue:
$1.97B
Net Income/Loss:
$92.93M
P/E Ratio:
30.81
EPS:
1.45
Net Cash Flow:
$459.60M
1W Performance:
-1.61%
1M Performance:
+6.13%
6M Performance:
+6.64%
1Y Performance:
+3.06%
1-Day Range:
$43.78
$44.95
1-Week Range:
$43.78
$46.08
52-Week Range:
$39.03
$47.44
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
44.67 | 9.93B | 1.97B | 92.93M | 459.60M | 0.4066 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
August 2025 Options Now Available For Qiagen (QGEN) - Nasdaq
Qiagen Announces AFM Notification on BlackRock Shareholding - TipRanks
Qiagen Highlights BlackRock’s Indirect Stake in Voting Rights Disclosure - TipRanks
State Street Corp Boosts Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret - MSN
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
QIAGEN Launches Ingenuity Pathway Analysis Interpret - Marketscreener.com
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data - Business Wire
Public Employees Retirement System of Ohio Buys Shares of 214,400 Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Shares Bought by Barclays PLC - MarketBeat
QIAGEN Unveils AI-Powered IPA Interpret Platform to Transform Biological Data Analysis - StockTitan
Qiagen (NYSE:QGEN) Stock Holdings Lifted by XTX Topco Ltd - MarketBeat
Qiagen (NYSE:QGEN) Given "Buy" Rating at Jefferies Financial Group - MarketBeat
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly - Simply Wall St
Point72 Asset Management L.P. Trims Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
Janus Henderson Group PLC Reduces Holdings in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements - MSN
Qiagen shares get Buy rating, $54 target from Jefferies By Investing.com - Investing.com Canada
Qiagen shares get Buy rating, $54 target from Jefferies - Investing.com
Jefferies Starts Qiagen NV (QGEN) at Buy - StreetInsider.com
QIAGEN Wins FDA Clearance of QIAstat-Dx Meningitis/Encephalitis Panel - MPO-mag
Quantinno Capital Management LP Has $3.56 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
25,658 Shares in Qiagen (NYSE:QGEN) Acquired by Verition Fund Management LLC - MarketBeat
Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound? - MSN
Fmr LLC Raises Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Should You Continue to Retain QIAGEN Stock in Your Portfolio Now? - MSN
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 321,182 Shares of Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation - Silicon Canals
Proteinase K Market to hit USD 2.5 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
Edgestream Partners L.P. Reduces Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Parkman Healthcare Partners LLC Decreases Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
219,245 Shares in Qiagen (NYSE:QGEN) Purchased by Holocene Advisors LP - MarketBeat
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance
Point72 Hong Kong Ltd Boosts Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Stock Holdings Increased by Public Sector Pension Investment Board - MarketBeat
Qiagen (NYSE:QGEN) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
FY2024 Earnings Forecast for Qiagen Issued By Zacks Research - MarketBeat
Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance
Martingale Asset Management L P Decreases Position in Qiagen (NYSE:QGEN) - MarketBeat
QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site - Yahoo Finance
QIAGEN announces new site in Barcelona for QIAstat-Dx operations - Medical Device Network
QIAGEN introduces new custom tools for microbial analysis - Yahoo Finance
Quantbot Technologies LP Has $3.31 Million Stake in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Expands Diagnostic Operations with New 8,000sqm Barcelona Facility for QIAstat-Dx | QGEN Stock News - StockTitan
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis - GlobeNewswire
QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients - br.ADVFN.com
Qiagen (NYSE:QGEN) Shares Sold by Citigroup Inc. - MarketBeat
QIAGEN Launches Groundbreaking Custom Microbial Analysis Tools for Digital PCR & NGS - StockTitan
QIAGEN Gains FDA Clearance for Latest Respiratory Mini-Panel Test - MPO-mag
Here's Why Qiagen (QGEN) is a Strong Momentum Stock - Yahoo Finance
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):